Natural History and Biological Study of Netherton Syndrome

Key facts

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Principal Investigator

Alain Hovnanian, MD, PhD

INSERM U1163

Intervention

Biopsy(other)

Enrollment

18 enrolled

Eligibility

All sexes

Timeline

2014 – 2016

Study locations (1)

• Imagine Institute for genetic diseases, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Netherton syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2, PHASE3NCT06953466
  Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
  Quoin Pharmaceuticals
• RECRUITINGPHASE1NCT06539507
  A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
  BioCryst Pharmaceuticals
• RECRUITINGPHASE1NCT06137157
  Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
  Azitra Inc.
• RECRUITINGPHASE2, PHASE3NCT05789056
  Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
  Quoin Pharmaceuticals
• ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05521438
  Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
  Quoin Pharmaceuticals

See all trials for Netherton syndrome →